| 000 | 01337 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517030751.0 | ||
| 264 | 0 | _c20151230 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1751-2441 | ||
| 024 | 7 |
_a10.1586/17512433.2015.1040393 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZink, Mathias | |
| 245 | 0 | 0 |
_aGlutamatergic agents for schizophrenia: current evidence and perspectives. _h[electronic resource] |
| 260 |
_bExpert review of clinical pharmacology _cMay 2015 |
||
| 300 |
_a335-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCorrell, Christoph U | |
| 773 | 0 |
_tExpert review of clinical pharmacology _gvol. 8 _gno. 3 _gp. 335-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/17512433.2015.1040393 _zAvailable from publisher's website |
| 999 |
_c24845663 _d24845663 |
||